Fluid deprivation test

Fluid Deprivation Test is a diagnostic procedure used to determine the causes of polyuria (excessive urination) and polydipsia (excessive thirst). These symptoms can be indicative of various conditions, including diabetes insipidus, diabetes mellitus, and psychogenic polydipsia. The test measures the body's ability to concentrate urine in response to fluid deprivation, helping to differentiate between these conditions.
Procedure[edit]
The fluid deprivation test typically begins in the morning. The patient is instructed to stop drinking fluids several hours before the test starts. During the test, the patient's weight, urine output, and urine concentration are monitored at regular intervals. Blood samples may also be taken to measure serum electrolytes and antidiuretic hormone (ADH) levels. The test continues until one of the following occurs: a significant decrease in body weight (usually 3-5% of body weight), a plateau in urine osmolality/concentration across three consecutive measurements, or the patient develops symptoms indicating the test should be stopped, such as significant discomfort or signs of dehydration.
Interpretation[edit]
The results of the fluid deprivation test help to distinguish between different types of diabetes insipidus and other conditions. If the patient's urine concentration increases significantly during the test, it suggests that the kidneys can concentrate urine normally when fluid intake is restricted, which may indicate psychogenic polydipsia or primary polydipsia. If the urine concentration remains low, it suggests a diagnosis of diabetes insipidus. Further differentiation between central (neurogenic) and nephrogenic diabetes insipidus can be made based on the response to administered ADH during the test. An increase in urine concentration after ADH administration suggests central diabetes insipidus, while little to no response suggests nephrogenic diabetes insipidus.
Risks and Considerations[edit]
The fluid deprivation test is generally safe but requires careful monitoring to avoid complications such as dehydration and electrolyte imbalance. It is contraindicated in patients with severe illness, unstable medical conditions, or those who cannot be adequately monitored during the test.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian